GDNF–Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease

Edgar R. Kramer*, Birgit Liss

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

<jats:p>Glial cell line‐derived neurotrophic factor (GDNF) and its canonical receptor Ret can signal together or independently to fulfill many important functions in the midbrain dopaminergic (DA) system. While Ret signaling clearly impacts on the development, maintenance and regeneration of the mesostriatal DA system, the physiological functions of GDNF for the DA system are still unclear. Nevertheless, GDNF is still considered to be an excellent candidate to protect and/or regenerate the mesostriatal DA system in Parkinson disease (PD). Clinical trials with GDNF on PD patients are, however, so far inconclusive. Here, we review the current knowledge of GDNF and Ret signaling and function in the midbrain DA system, and their crosstalk with proteins and signaling pathways associated with PD.</jats:p>
Original languageEnglish
Pages (from-to)3760-3772
Number of pages0
JournalFEBS Letters
Volume589
Issue number0
Early online date7 Nov 2015
DOIs
Publication statusPublished - 21 Dec 2015

Fingerprint

Dive into the research topics of 'GDNF–Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease'. Together they form a unique fingerprint.

Cite this